Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 58 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 8075900

    Melanoma associated peptide analogues and vaccines against melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  2. US 8071084

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  3. US 8071113

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  4. US 8071746

    Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  5. US 8067530

    Scytovirin domain 1 related polypeptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  6. US 8063195

    Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  7. US 8058248

    Foot and mouth disease virus vaccine comprising interferons

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  8. US 8053443

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  9. US 8053422

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  10. US 8048427

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  11. US 8044189

    Bacillus anthracis protective antigen nucleic acid sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  12. US 8044187

    Human luteinizing hormone superagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  13. US 8039585

    Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  14. US 8039003

    Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  15. US 8039593

    Antibodies and immunotoxins that target human glycoprotein NMB

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  16. US 8034334

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  17. US 8029809

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  18. US 8030280

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  19. US 8030285

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  20. US 8022175

    Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  21. US 8017130

    Method of accelerated vaccination against Ebola viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  22. US 8012730

    Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  23. US 8008316

    Azonafide derived tumor and cancer targeting compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  24. US 8008266

    Methods of treating cancer using immunostimulatory oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.